SwePub
Tyck till om SwePub Sök här!
Sök i SwePub databas

  Utökad sökning

Booleska operatorer måste skrivas med VERSALER

AND är defaultoperator och kan utelämnas

Träfflista för sökning "AMNE:(MEDICAL AND HEALTH SCIENCES Clinical Medicine Cardiac and Cardiovascular Systems) "

Sökning: AMNE:(MEDICAL AND HEALTH SCIENCES Clinical Medicine Cardiac and Cardiovascular Systems)

  • Resultat 31-40 av 13848
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
31.
  • Abdellah, Tebani, et al. (författare)
  • Integration of molecular profiles in a longitudinal wellness profiling cohort.
  • 2020
  • Ingår i: Nature communications. - : Springer Science and Business Media LLC. - 2041-1723. ; 11:1
  • Tidskriftsartikel (refereegranskat)abstract
    • An important aspect of precision medicine is to probe the stability in molecular profiles among healthy individuals over time. Here, we sample a longitudinal wellness cohort with 100 healthy individuals and analyze blood molecular profiles including proteomics, transcriptomics, lipidomics, metabolomics, autoantibodies and immune cell profiling, complemented with gut microbiota composition and routine clinical chemistry. Overall, our results show high variation between individuals across different molecular readouts, while the intra-individual baseline variation is low. The analyses show that each individual has a unique and stable plasma protein profile throughout the study period and that many individuals also show distinct profiles with regards to the other omics datasets, with strong underlying connections between the blood proteome and the clinical chemistry parameters. In conclusion, the results support an individual-based definition of health and show that comprehensive omics profiling in a longitudinal manner is a path forward for precision medicine.
  •  
32.
  • Fromentin, S., et al. (författare)
  • Microbiome and metabolome features of the cardiometabolic disease spectrum
  • 2022
  • Ingår i: Nature Medicine. - : Springer Science and Business Media LLC. - 1078-8956 .- 1546-170X. ; 28:2
  • Tidskriftsartikel (refereegranskat)abstract
    • By studying individuals along a spectrum of cardiometabolic disease and adjusting for effects of lifestyle and medication, this investigation identifies alterations of the metabolome and microbiome from dysmetabolic conditions, such as obesity and type 2 diabetes, to ischemic heart disease. Previous microbiome and metabolome analyses exploring non-communicable diseases have paid scant attention to major confounders of study outcomes, such as common, pre-morbid and co-morbid conditions, or polypharmacy. Here, in the context of ischemic heart disease (IHD), we used a study design that recapitulates disease initiation, escalation and response to treatment over time, mirroring a longitudinal study that would otherwise be difficult to perform given the protracted nature of IHD pathogenesis. We recruited 1,241 middle-aged Europeans, including healthy individuals, individuals with dysmetabolic morbidities (obesity and type 2 diabetes) but lacking overt IHD diagnosis and individuals with IHD at three distinct clinical stages-acute coronary syndrome, chronic IHD and IHD with heart failure-and characterized their phenome, gut metagenome and serum and urine metabolome. We found that about 75% of microbiome and metabolome features that distinguish individuals with IHD from healthy individuals after adjustment for effects of medication and lifestyle are present in individuals exhibiting dysmetabolism, suggesting that major alterations of the gut microbiome and metabolome might begin long before clinical onset of IHD. We further categorized microbiome and metabolome signatures related to prodromal dysmetabolism, specific to IHD in general or to each of its three subtypes or related to escalation or de-escalation of IHD. Discriminant analysis based on specific IHD microbiome and metabolome features could better differentiate individuals with IHD from healthy individuals or metabolically matched individuals as compared to the conventional risk markers, pointing to a pathophysiological relevance of these features.
  •  
33.
  • Ebbers, Tino, 1972- (författare)
  • Flow Imaging: Cardiac Applications of 3D Cine Phase-Contrast MRI
  • 2011
  • Ingår i: Current Cardiovascular Imaging Reports. - : Springer Science and Business Media LLC. - 1941-9074 .- 1941-9066. ; 4:2, s. 127-133
  • Forskningsöversikt (refereegranskat)abstract
    • Global and regional blood flow dynamics are of pivotal importance to cardiac function. Fluid mechanical forces can affect hemolysis and platelet aggregation, as well as myocardial remodeling. In recent years, assessment of blood flow patterns based on time-resolved, three-dimensional, three-directional phase-contrast MRI (3D cine PC MRI) has become possible and rapidly gained popularity. Initially, this technique was mainly known for its intuitive and appealing visualizations of the cardiovascular blood flow. Most recently, the technique has begun to go beyond compelling images toward comprehensive and quantitative assessment of blood flow. In this article, cardiac applications of 3D cine PC MRI data are discussed, starting with a review of the acquisition and analysis techniques, and including descriptions of promising applications of cardiac 3D cine PC MRI for the clinical evaluation of myocardial, valvular, and vascular disorders.
  •  
34.
  • Perk, Joep, et al. (författare)
  • Study of patient information after percutaneous coronary intervention (SPICI) : should prevention programmes become more effective?
  • 2015
  • Ingår i: EuroIntervention. - : EuroPCR. - 1774-024X .- 1969-6213. ; 10:11, s. e1-e7
  • Tidskriftsartikel (refereegranskat)abstract
    • Aims: This cross-sectional observational study was designed to evaluate the uptake and outcome of patient education after percutaneous coronary intervention (PCI).Methods and results: A questionnaire containing 41 items was handed out to consecutive patients from randomly selected Swedish hospitals after PCI. Questions concerned the patient's attribution of the cause of the cardiac event, perception of the information provided by physicians and nurses, and a self-assessment of changes in lifestyle post PCI regarding tobacco, physical activity, food habits and stress. Replies were obtained from 1,073 patients (reply rate 67%). Non-modifiable risk factors (age, heredity) were attributed a higher rate as the cause of disease compared to modifiable factors (smoking, physical activity, food habits). Most patients (67%) perceived they were cured, and 38% perceived from the given information that there was no need to change their habits. A mere 27% reported that they still had cardiovascular disease and needed behavioural change. After PCI, 16% continued to use tobacco; half of these were offered smoking cessation support. In spite of an 80% referral rate to cardiac rehabilitation, one out of two patients did not enrol. Fewer than half were regularly physically active. Nutritional counselling was provided to 71%, but only 40% changed food habits. Stress management programmes were rarely provided.Conclusions: Current preventive practice scarcely meets the challenge posed by the progress in modern invasive cardiology. The Study of Patient Information after percutaneous Coronary Intervention (SPICI) motivates an in-depth revision and adaptation of cardiac rehabilitation programmes in order to improve patient understanding of the disease, and to support greater compliance with a cardioprotective lifestyle.
  •  
35.
  • Leu Agelii, Monica, 1977, et al. (författare)
  • Low vitamin D status in relation to cardiovascular disease and mortality in Swedish women - Effect of extended follow-up
  • 2017
  • Ingår i: Nutrition Metabolism and Cardiovascular Diseases. - : Elsevier BV. - 0939-4753 .- 1590-3729. ; 27:12, s. 1143-1151
  • Tidskriftsartikel (refereegranskat)abstract
    • Background and aims: The impact of vitamin D concentrations on subsequent cardiovascular disease (CVD) and overall mortality has been generally examined for periods under two decades. The magnitude of the association may depend on follow-up length. We aimed to investigate the relationship between baseline vitamin D and risk of total CVD, stroke and all-cause mortality over three decades of follow-up. Secondly, we aimed to assess how follow-up affects the associations. Methods and results: Concentrations of 25-hydroxyvitamin D (25D) were measured in a population-based sample of 1227 middle-aged women using serum collected at baseline and categorized into low (lowest 25D quartile) vs high 25D status (upper three 25D quartiles). Hazard ratio (HR) of the endpoints was estimated for low 25D. The impact of follow-up was examined in intermediary analyses where follow-up was interrupted up to four times, each time decreasing it by five years. There were 596 cardiovascular events and 635 participants died. During the first 17 years, the low 25D group experienced a 29% higher CVD risk and 3.3-fold higher stroke risk after accounting for confounders. Longer follow-up diminished significantly these risks and 25D status had no contribution at 32 years. For mortality, the decline over time was less dramatic, with HR = 1.96 (1.25; 3.08) at 17 years and HR = 1.42 (1.17; 1.72) at 37 years. Conclusion: Low 25D status increased the risk for all endpoints, but a lengthy follow-up diminished these risks towards the null. The impact of follow-up depends on the outcome. Future studies of 25D and disease should use repeated 25D assessments. (C) 2017 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B. V. All rights reserved.
  •  
36.
  • Ingvarsson, R. F., et al. (författare)
  • Good survival rates in systemic lupus erythematosus in southern Sweden, while the mortality rate remains increased compared with the population.
  • 2019
  • Ingår i: Lupus. - : SAGE Publications. - 1477-0962 .- 0961-2033. ; 28:12, s. 1488-1494
  • Tidskriftsartikel (refereegranskat)abstract
    • To ascertain the mortality rate and causes of death in patients with systemic lupus erythematosus (SLE) within a defined region in southern Sweden during the time period 1981-2014 and determine whether these have changed over time.In 1981, a prospective observation study of patients with SLE was initiated in southern Sweden. All incident SLE patients within a defined geographic area were identified using previously validated methods including diagnosis and immunology registers. Patients with a confirmed SLE diagnosis were then followed prospectively at the Department of Rheumatology in Lund. Clinical data was collected at regular visits. Patients were recruited from 1981 to 2006 and followed until 2014. The patient cohort was split into two groups based on the year of diagnosis to determine secular trends. Causes of death were retrieved from medical records and from the cause of death registry at The National Board of Health and Welfare in Sweden.In all, 175 patients were diagnosed with SLE during the study period. A total of 60 deaths occurred during a total of 3053 years of follow-up. In the first half of the study inclusion period 46 patients died, compared with 14 in the latter. The majority of patients (51.7%) died of cardiovascular disease. Infections caused 15% of the deaths and malignancy was the cause of death in 13.3% of patients. SLE was the main cause of death for 6.7% of the patients and a contributing factor for half of the patients. Standardized mortality ratio was increased in patients by a factor of 2.5 compared with the general population. Deaths occurred at an even rate throughout the whole observation period. No significant difference in standardized mortality ratio was observed between genders but was increased in older female patients. Furthermore, secular mortality trends were not identified.In this long-term epidemiologic follow-up study of incident SLE, we report a substantially raised mortality rate amongst SLE patients compared with the general population. The mortality rates have not changed significantly during the observation period that spanned three decades. The main cause of death was cardiovascular disease and this finding was consistent over time.
  •  
37.
  • Carlsson, Axel C, et al. (författare)
  • Endostatin predicts mortality in patients with acute dyspnea - a cohort study of patients seeking care in emergency departments.
  • 2019
  • Ingår i: Clinical Biochemistry. - : Elsevier BV. - 0009-9120 .- 1873-2933. ; 75
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: Increased levels of circulating endostatin predicts cardiovascular morbidity and impaired kidney function in the general population. The utility of endostatin as a risk marker for mortality in the emergency department (ED) has not been reported.AIM: Our main aim was to study the association between plasma endostatin and 90-day mortality in an unselected cohort of patients admitted to the ED for acute dyspnea. Design Circulating endostatin was analyzed in plasma from 1710 adults and related to 90-day mortality in Cox proportional hazard models adjusted for age, sex, body mass index, oxygen saturation, respiratory rate, body temperature, C-reactive protein, lactate, creatinine and medical priority according to the Medical Emergency Triage and Treatment System-Adult score (METTS-A). The predictive value of endostatin for mortality was evaluated with receiver operating characteristic (ROC) analysis and compared with the clinical triage scoring system and age.RESULTS: Each one standard deviation increment of endostatin was associated with a HR of 2.12 (95 % CI 1.31-3.44 p< 0.01) for 90-day mortality after full adjustment. Levels of endostatin were significantly increased in the group of patients with highest METTS-A (p<0.001). When tested for the outcome 90-day mortality, the area under the ROC curve (AUC) was 0.616 for METTS-A, 0.701 for endostatin, 0.708 for METTS -A and age and 0.738 for METTS-A, age and levels of endostatin.CONCLUSIONS: In an unselected cohort of patients admitted to the ED with acute dyspnea, endostatin had a string association to 90-day mortality and improved prediction of 90-day mortality in the ED beyond the clinical triage scoring system and age with 3 %.
  •  
38.
  • Hållmarker, Ulf, 1946-, et al. (författare)
  • Risk of recurrent ischaemic events after myocardial infarction in long-distance ski race participants
  • 2016
  • Ingår i: European Journal of Preventive Cardiology. - : Oxford University Press (OUP). - 2047-4873 .- 2047-4881. ; 23:3, s. 282-290
  • Tidskriftsartikel (refereegranskat)abstract
    • Aims: To study whether a high level of physical activity prior to myocardial infarction (MI) also protects against recurrent MI (re-MI) or death.Methods and Results: A longitudinal study of a primary cohort consisting of 204,038 skiers with a proved substantially high level of physical activity in the world's largest long-distance ski race, Vasaloppet, and 499,543 non-skiers selected from the Swedish population. Individuals with severe diseases at baseline were excluded. In the nationwide clinical register, Swedeheart, we identified 7092 individuals with a first MI incident between 1989 and 2010. Of these, 1039 (0.5%) were skiers and 6053 (1.2%) were non-skiers. One hundred and sixty-three (15.7%) skiers and 1352 (22.3%) non-skiers suffered a re-MI or died during follow-up (median 4.44 years), corresponding to an incidence rate of 38.9 (95% confidence interval (CI) 33.2-45.4)/1000 person-years and 55.6 (95% CI 52.7-58.7)/1000 person-years, respectively. Severity of MI in both groups was the same. For skiers compared to non-skiers the unadjusted hazard ratio (HR) for re-MI was 0.66 (95% CI 0.52-0.82). For death or re-MI, HR was 0.70 (95% CI 0.59-0.82) with consistent results in subgroups based on race year, age, gender, education level, marital status. After adjustment for also smoking, diabetes, hypertension and cardiovascular medication, HR was 0.80 (95% CI 0.67-0.97).Conclusions: This large cohort study supports the hypothesis that patients with MI and with prior physical activity and healthy lifestyle, as evidenced by their participation in a long-distance ski race, have a lower risk of subsequent re-MI or death. 
  •  
39.
  • Palm, Andreas, 1971-, et al. (författare)
  • Course of DISease in patients reported to the Swedish CPAP Oxygen and VEntilator RegistrY (DISCOVERY) with population-based controls
  • 2020
  • Ingår i: BMJ Open. - : BMJ. - 2044-6055. ; 10:11
  • Tidskriftsartikel (refereegranskat)abstract
    • Purpose Chronic hypoxic and hypercapnic respiratory failure and obstructive sleep apnoea (OSA) are chronic diseases associated with decreased quality of life and increased mortality. The rationale behind the set up the retrospective nationwide DISCOVERY cohort was to study several questions including disease course and risk factors for incident disease, impaired quality of life, hospitalisation risk and mortality in patients with chronic respiratory failure with long-term oxygen therapy (LTOT), long-term mechanical ventilation (LTMV) and obstructive sleep apnoea (OSA) on treatment with continuous positive airway pressure (CPAP). Participants and settings Data from the national quality registry for respiratory insufficiency and sleep apnoea (Swedevox) and a population-based control group from Statistics Sweden were merged with governmental registries, the Swedish Cancer Registry, the Swedish Cause of Death Registry, the Swedish Drug registry, the Swedish National Patient Registry and the Swedish Dental Health Registry and with national quality registries for diabetes, rheumatic diseases (Swedish Rheumatology Quality Registry), stroke (RiksStroke), heart failure (RiksSvikt), acute heart infarction care (SwedeHeart) and intensive care (SIR) and with socioeconomic data from Statistics Sweden (SCB). Findings to date The cohort comprises 25 804 unique patients with LTOT since 1987 (54.1% females, age 73.3±9.8 years, body mass index (BMI) 26.6±6.5 kg/m 2), 8111 with LTMV since 1996 (48.6% women, age 60.6±16.9 years, BMI 32.9±10.8 kg/m 2), 65 809 with OSA on CPAP since 2010 (29.5% women, age 57.2±12.5 years, BMI 31.9±6.2 kg/m 2) and 145 224 persons in a population-based control group from same time span up to March 2018 (51.7% women, age 49.9±20.4 year, BMI 24.9±4.0 years). Future plans In patients with chronic respiratory failure and sleep apnoea important questions regarding comorbidity burden, hospitalisation rate, mortality and treatment outcomes are still unexplored to a large extent. The DISCOVERY cohort will provide unique opportunities by its size and comprehensiveness to fill this clinically relevant gap of knowledge. © 2020 Author(s). Published by BMJ.
  •  
40.
  • Liu, Xixi, 1995, et al. (författare)
  • Deep Nearest Neighbors for Anomaly Detection in Chest X-Rays
  • 2024
  • Ingår i: Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). - 1611-3349 .- 0302-9743. ; 14349 LNCS, s. 293-302
  • Konferensbidrag (refereegranskat)abstract
    • Identifying medically abnormal images is crucial to the diagnosis procedure in medical imaging. Due to the scarcity of annotated abnormal images, most reconstruction-based approaches for anomaly detection are trained only with normal images. At test time, images with large reconstruction errors are declared abnormal. In this work, we propose a novel feature-based method for anomaly detection in chest x-rays in a setting where only normal images are provided during training. The model consists of lightweight adaptor and predictor networks on top of a pre-trained feature extractor. The parameters of the pre-trained feature extractor are frozen, and training only involves fine-tuning the proposed adaptor and predictor layers using Siamese representation learning. During inference, multiple augmentations are applied to the test image, and our proposed anomaly score is simply the geometric mean of the k-nearest neighbor distances between the augmented test image features and the training image features. Our method achieves state-of-the-art results on two challenging benchmark datasets, the RSNA Pneumonia Detection Challenge dataset, and the VinBigData Chest X-ray Abnormalities Detection dataset. Furthermore, we empirically show that our method is robust to different amounts of anomalies among the normal images in the training dataset. The code is available at: https://github.com/XixiLiu95/deep-kNN-anomaly-detection.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 31-40 av 13848
Typ av publikation
tidskriftsartikel (11866)
forskningsöversikt (609)
konferensbidrag (574)
doktorsavhandling (473)
bokkapitel (168)
annan publikation (120)
visa fler...
bok (15)
rapport (10)
samlingsverk (redaktörskap) (7)
licentiatavhandling (3)
patent (2)
recension (1)
visa färre...
Typ av innehåll
refereegranskat (12129)
övrigt vetenskapligt/konstnärligt (1689)
populärvet., debatt m.m. (29)
Författare/redaktör
Melander, Olle (437)
Erlinge, David (375)
Engström, Gunnar (317)
Swedberg, Karl, 1944 (262)
Henein, Michael Y. (241)
Lind, Lars (231)
visa fler...
Nilsson, Jan (225)
Wallentin, Lars, 194 ... (206)
Rosengren, Annika, 1 ... (205)
Arheden, Håkan (197)
Hedblad, Bo (193)
Herlitz, Johan, 1949 (189)
James, Stefan, 1964- (189)
Wallentin, Lars (180)
Nilsson, Peter (175)
Lindahl, Bertil, 195 ... (163)
Blomström-Lundqvist, ... (162)
Jernberg, Tomas (159)
Omerovic, Elmir, 196 ... (158)
Nilsson, Peter M (157)
Gottsäter, Anders (152)
Carlsson, Marcus (149)
Söderberg, Stefan (139)
Olsson, Bertil (137)
Fröbert, Ole, 1964- (133)
Dellborg, Mikael, 19 ... (130)
Wanhainen, Anders (129)
Held, Claes, 1956- (127)
Redfors, Björn (125)
Dahlström, Ulf (124)
Goncalves, Isabel (121)
Engblom, Henrik (121)
Acosta, Stefan (115)
Sundquist, Kristina (114)
Lund, Lars H. (113)
Hagström, Emil (112)
Pahlm, Olle (112)
Johansson, Bengt (112)
Koul, Sasha (111)
Rådegran, Göran (110)
Orho-Melander, Marju (109)
Lopes, Renato D. (107)
Jeppsson, Anders, 19 ... (105)
Romeo, Stefano, 1976 (103)
Boman, Kurt (101)
Sundström, Johan, Pr ... (101)
Sundquist, Jan (99)
Ärnlöv, Johan, 1970- (98)
Nilsson, Johan (98)
Ricci, Fabrizio (98)
visa färre...
Lärosäte
Lunds universitet (5785)
Uppsala universitet (3236)
Göteborgs universitet (2951)
Karolinska Institutet (2501)
Umeå universitet (1685)
Linköpings universitet (1236)
visa fler...
Örebro universitet (751)
Högskolan i Borås (276)
Kungliga Tekniska Högskolan (200)
Jönköping University (188)
Linnéuniversitetet (186)
Högskolan Dalarna (173)
Chalmers tekniska högskola (139)
Stockholms universitet (124)
Sveriges Lantbruksuniversitet (111)
Malmö universitet (100)
Gymnastik- och idrottshögskolan (71)
Högskolan i Halmstad (53)
Högskolan i Skövde (52)
Mälardalens universitet (46)
Mittuniversitetet (42)
Högskolan Väst (39)
Luleå tekniska universitet (27)
Högskolan Kristianstad (20)
Högskolan i Gävle (20)
Röda Korsets Högskola (15)
Blekinge Tekniska Högskola (12)
Marie Cederschiöld högskola (8)
Sophiahemmet Högskola (8)
Karlstads universitet (7)
Handelshögskolan i Stockholm (4)
RISE (4)
Södertörns högskola (1)
visa färre...
Språk
Engelska (13509)
Svenska (308)
Tyska (7)
Isländska (5)
Spanska (4)
Ryska (3)
visa fler...
Italienska (3)
Odefinierat språk (2)
Portugisiska (2)
Kinesiska (2)
Franska (1)
Norska (1)
Polska (1)
visa färre...
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (13848)
Naturvetenskap (130)
Samhällsvetenskap (108)
Teknik (106)
Lantbruksvetenskap (24)
Humaniora (6)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy